venBio Partners LLC Q2 2025 Filing

Filed August 14, 2025

Portfolio Value

$114.8B

Holdings

6

Report Date

Q2 2025

Filing Type

13F-HR

All Holdings (6 positions)

#StockSharesValue% PortfolioType
1
PHVSPHARVARIS N V
4,289,304$75.5B65.78%
2
HRMYHARMONY BIOSCIENCES HLDGS IN
489,194$15.5B13.47%
3
ALMSALUMIS INC
4,619,803$13.9B12.08%
4
LYELLYELL IMMUNOPHARMA INC
473,479$4.2B3.65%
5
ALXOALX ONCOLOGY HLDGS INC
9,699,925$4.0B3.51%
6
ARTVARTIVA BIOTHERAPEUTICS INC
1,148,975$1.7B1.51%